Sarcopenia is an important component of cachexia associated with cancer, and their high incidence in cancer patients emphasizes the need for a better understanding of its mechanisms, which can result in better therapeutic interventions to reverse this situation and improve the prognosis. Our hypothesis is that the plasma concentration of IL-6 and c-terminal agrin is directly correlated with the loss of muscle mass and development of cachexia.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Agrin fragment c-terminus CAF in cancer and cancer cachexia
Timeframe: 1 month
Agrin fragment c-terminus CAF in cancer sarcopenia
Timeframe: 1 month
Agrin fragment c-terminus CAF and IL-6 levels
Timeframe: 1 month
Agrin fragment c-terminus (CAF) and IL-6 and lean body mass
Timeframe: 1 month